particles by reducing expression of the heparan sulphate
proteoglycan perlecan on hepatocytes
4
. Associations of
atherosclerosis and atherosclerosis risk factors with
glycaemia have been shown over a broad range of glucose
tolerance, from normal to diabetic. Postprandial hypergly-
caemia may be more predictive of atherosclerosis than is
fasting plasma glucose level or haemoglobin A1c
11
.
Whether postprandial hyperglycaemia is an independent
risk factor is controversial and requires further study.
Mechanisms of hyperglycaemia-induced damage
How do these diverse microvascular and macrovascular
pathologies all result from hyperglycaemia? Four main
hypotheses about how hyperglycaemia causes diabetic
complications have generated a large amount of data, as well
as several clinical trials based on specific inhibitors of these
mechanisms. The four hypotheses are: increased polyol
pathway flux; increased advanced glycation end-product
(AGE) formation; activation of protein kinase C (PKC)
isoforms; and increased hexosamine pathway flux. Until
recently there was no unifying hypothesis linking these four
mechanisms.
Increased polyol pathway flux
Aldose reductase (alditol:NAD(P)
+
1-oxidoreductase, EC
1.1.1.21) is the first enzyme in the polyol pathway. It is a
cytosolic, monomeric oxidoreductase that catalyses the
NADPH-dependent reduction of a wide variety of carbonyl
compounds, including glucose. Its crystal structure has a
single domain folded into an eight-stranded parallel
a/b-barrel motif, with the substrate-binding site located in
a cleft at the carboxy-terminal end of the
b-barrel
12
. Aldose
Biochemistry and molecular cell
biology of diabetic complications
Michael Brownlee
Departments of Medicine and Pathology, and Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx,
New York 10461, USA (e-mail: brownlee@aecom.yu.edu)
Chia sẻ với bạn bè của bạn: |